125 related articles for article (PubMed ID: 1097512)
1. Hyperacute rejection and enhancement of mouse skin grafts by antibodies with a distinct specificity.
Jansen JL; Koene RA; Kamp GJ; Hagemann JF; Wijdeveld PG
J Immunol; 1975 Aug; 115(2):392-4. PubMed ID: 1097512
[TBL] [Abstract][Full Text] [Related]
2. Isolation of pure IgG subclasses from mouse alloantiserum and their activity in enhancement and hyperacute rejection of skin allografts.
Jansen JL; Gerard AP; Kamp J; Tamboer WP; Wijdeveld PG
J Immunol; 1975 Aug; 115(2):387-91. PubMed ID: 807636
[TBL] [Abstract][Full Text] [Related]
3. Ehancement and hyperacute rejection of skin grafts in the mousefailure to separate cytotoxic and enhancing antibodies from alloantiserum with physicochemical methods.
Jansen JL; Koene RA; Kamp GJ; Gerlag PG; Wijdeveld PA
J Immunol; 1975 May; 114(5):1557-62. PubMed ID: 804518
[TBL] [Abstract][Full Text] [Related]
4. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
de Waal RM; Capel PJ; Koene RA
J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
[TBL] [Abstract][Full Text] [Related]
5. Passive enhancement of mouse skin allografts by alloantibodies is Fc dependent.
Capel PJ; Tamboer WP; de Waal RM; Jansen JL; Koene RA
J Immunol; 1979 Feb; 122(2):421-5. PubMed ID: 368240
[TBL] [Abstract][Full Text] [Related]
6. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
Isakov N; Bach FH
J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
[TBL] [Abstract][Full Text] [Related]
7. The immunologic response to xenografts. Recognition of mouse H-2 histocompatibility antigens by the rat.
Sachs DH; Winn HJ; Russell PS
J Immunol; 1971 Aug; 107(2):481-92. PubMed ID: 4936290
[No Abstract] [Full Text] [Related]
8. Hyperacute rejection of skin allografts in the mouse. Sensitivity of ingrowing skin grafts to the action of alloantibody and rabbit complement.
Gerlag PG; Koene RA; Hagemann JF; Wijdeveld PG
Transplantation; 1975 Oct; 20(4):308-13. PubMed ID: 1099736
[TBL] [Abstract][Full Text] [Related]
9. Effects of monoclonal anti-H-2Ld and anti-H-2Dd alloantibodies in the immunological enhancement of skin grafts and neonatal heart grafts in the mouse.
Lems SP; Jacobs CW; Capel PJ; Koene RA
J Immunol; 1987 Apr; 138(7):2082-7. PubMed ID: 3549896
[TBL] [Abstract][Full Text] [Related]
10. Immune regulation by monoclonal antibodies: failure to enhance mouse skin allografts.
Lems SP; Tax WJ; Capel PJ; Koene RA
J Immunol; 1983 Jul; 131(1):86-91. PubMed ID: 6345667
[TBL] [Abstract][Full Text] [Related]
11. The dominant role of Ia antibodies in the passive enhancement of H-2 incompatible skin grafts.
Staines NA; Guy K; Davies DA
Eur J Immunol; 1975 Nov; 5(11):782-9. PubMed ID: 802473
[TBL] [Abstract][Full Text] [Related]
12. A new in vitro test evaluating anti-lymphocyte serum potency.
Bach JF; Dardenne M; Dormont J; Antoine B
Transplant Proc; 1969 Mar; 1(1):403-7. PubMed ID: 4944250
[No Abstract] [Full Text] [Related]
13. Hyperacute rejection of skin allografts in the mouse by the administration of alloantibody and rabbit complement.
Koene RA; Gerlag PG; Hagemann JF; van Haelst UJ; Wijdeveld PG
J Immunol; 1973 Aug; 111(2):520-6. PubMed ID: 4577882
[No Abstract] [Full Text] [Related]
14. Connection between the anti-organ and anti-nuclear titres of antilymphocyte sera and their inhibitory effect on skin graft rejection in mice.
Fekete B; Petrányi G; Szegedi G; Szabó G
Haematologia (Budap); 1971; 5(4):419-23. PubMed ID: 4948255
[No Abstract] [Full Text] [Related]
15. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
Duc HT; Kinsky RG; Voisin GA
Ann Immunol (Paris); 1979; 130C(3):461-74. PubMed ID: 475347
[TBL] [Abstract][Full Text] [Related]
16. Role of the antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation.
Trento A; Hardesty RL; Griffith BP; Zerbe T; Kormos RL; Bahnson HT
J Thorac Cardiovasc Surg; 1988 Jan; 95(1):37-41. PubMed ID: 2447445
[TBL] [Abstract][Full Text] [Related]
17. Anti-Gal antibody-mediated skin graft rejection requires a threshold level of Gal expression.
Murray-Segal L; Gock H; Cowan PJ; d'Apice AJ
Xenotransplantation; 2008 Feb; 15(1):20-6. PubMed ID: 18333910
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
McKenzie IF; Snell GD
Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
[No Abstract] [Full Text] [Related]
20. The protective effect of F(ab') 2 and succinylated IgG in the early treatment of hyperacute rejection in the primate.
Habal MB; Carpenter CB; Kobayashi K; Bush GJ; Misra M; Birtch AG
Transplant Proc; 1973 Mar; 5(1):601-6. PubMed ID: 4633093
[No Abstract] [Full Text] [Related]
[Next] [New Search]
